Single-dose intravenous simvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in the rat

J Pharmacol Sci. 2006 Dec;102(4):413-7. doi: 10.1254/jphs.sce06002x. Epub 2006 Nov 28.

Abstract

The effect of acute pretreatment with a single dose of simvastatin (1 mg/kg, i.v.; 30 min before ischemia) on renal dysfunction caused by ischemia-reperfusion (I/R) injury in the rat was investigated. I/R injury was induced by clamping both renal vascular pedicles for 45 min, followed by 4 h of reperfusion with saline (2 ml/kg per hour). Simvastatin significantly improved both parameters of glomerular and tubular dysfunction (e.g., creatinine levels and fractional excretion of Na(+), respectively) and especially improved the histological score, compared to control I/R-injured rats treated with saline or 10% DMSO only.

MeSH terms

  • Animals
  • Creatinine / blood
  • Disease Models, Animal
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Injections, Intravenous
  • Kidney / blood supply
  • Kidney / drug effects*
  • Kidney / pathology
  • Male
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / blood
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control*
  • Reperfusion Injury / urine
  • Simvastatin / administration & dosage
  • Simvastatin / pharmacology*
  • Simvastatin / therapeutic use
  • Sodium / urine
  • Urea / blood

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Urea
  • Sodium
  • Simvastatin
  • Creatinine